218 related articles for article (PubMed ID: 32737264)
1. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials.
Shammas NW; Jones-Miller S; Shammas GA; Shammas WJ
J Invasive Cardiol; 2020 Aug; 32(8):289-294. PubMed ID: 32737264
[TBL] [Abstract][Full Text] [Related]
2. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
[TBL] [Abstract][Full Text] [Related]
3. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
Shammas NW; Shammas GA; Banerjee S; Popma JJ; Mohammad A; Jerin M
J Endovasc Ther; 2016 Apr; 23(2):339-46. PubMed ID: 26921281
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis).
Dippel EJ; Makam P; Kovach R; George JC; Patlola R; Metzger DC; Mena-Hurtado C; Beasley R; Soukas P; Colon-Hernandez PJ; Stark MA; Walker C;
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):92-101. PubMed ID: 25499305
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
6. Jetstream Atherectomy Followed by Paclitaxel-Coated Balloons versus Balloon Angioplasty Followed by Paclitaxel-Coated Balloons: Twelve-Month Exploratory Results of the Prospective Randomized JET-RANGER Study.
Shammas NW; Purushottam B; Shammas WJ; Christensen L; Shammas G; Weakley D; Jones-Miller S;
Vasc Health Risk Manag; 2022; 18():603-615. PubMed ID: 35942041
[TBL] [Abstract][Full Text] [Related]
7. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
8. Shockwave™ Lithoplasty in Combination With Atherectomy in Treating Severe Calcified Femoropopliteal and Iliac Artery Disease: A Single-Center Experience.
Radaideh Q; Shammas NW; Shammas WJ; Shammas GA
Cardiovasc Revasc Med; 2021 Jan; 22():66-70. PubMed ID: 32563711
[TBL] [Abstract][Full Text] [Related]
9. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
[TBL] [Abstract][Full Text] [Related]
10. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry.
Gray WA; Garcia LA; Amin A; Shammas NW;
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):506-511. PubMed ID: 29331436
[TBL] [Abstract][Full Text] [Related]
11. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
12. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
[TBL] [Abstract][Full Text] [Related]
13. Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study.
Shammas NW; Shammas G; Christensen L; Jones-Miller S;
Vasc Health Risk Manag; 2023; 19():133-137. PubMed ID: 36936551
[TBL] [Abstract][Full Text] [Related]
14. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
Shammas NW; Shammas GA; Helou TJ; Voelliger CM; Mrad L; Jerin M
Cardiovasc Revasc Med; 2012; 13(4):224-7. PubMed ID: 22575073
[TBL] [Abstract][Full Text] [Related]
15. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.
Armstrong EJ; Thiruvoipati T; Tanganyika K; Singh GD; Laird JR
J Endovasc Ther; 2015 Aug; 22(4):506-13. PubMed ID: 26130385
[TBL] [Abstract][Full Text] [Related]
16. Clinical Safety and Efficacy of Rotational Atherectomy in Japanese Patients with Peripheral Arterial Disease Presenting Femoropopliteal Lesions: The J-SUPREME and J-SUPREME II Trials.
Iida O; Urasawa K; Shibata Y; Yamamoto Y; Ando H; Fujihara M; Nakama T; Miyashita Y; Mori S; Diaz-Cartelle J; Soga Y
J Endovasc Ther; 2022 Apr; 29(2):240-247. PubMed ID: 34510954
[TBL] [Abstract][Full Text] [Related]
17. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center.
Shammas NW; Shammas GA; Jerin M
J Endovasc Ther; 2013 Dec; 20(6):844-52. PubMed ID: 24325703
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
[No Abstract] [Full Text] [Related]
19. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
Shammas NW; Jones-Miller S; Lemke J
J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
